Biomed Healthtech Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 18-07-2024
- Paid Up Capital ₹ 0.88 M
as on 18-07-2024
- Company Age 35 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 8.00 M
as on 18-07-2024
- Revenue 20.30%
(FY 2022)
- Profit -15.70%
(FY 2022)
- Ebitda -13.22%
(FY 2022)
- Net Worth 1.93%
(FY 2022)
- Total Assets -15.56%
(FY 2022)
About Biomed Healthtech
The Corporate was formerly known as Biomed Importers Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.88 M.
The company has closed loans amounting to ₹8.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mukesh Daftary, Nirav Suresh, and Mayuri Daftary serve as directors at the Company.
- CIN/LLPIN
U51507MH1989PTC052161
- Company No.
052161
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jun 1989
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Biomed Healthtech Private Limited offer?
Biomed Healthtech Private Limited offers a wide range of products and services, including Surgical Instruments & Accessories, Tissue Forceps, Eye Testing Machines, Ophthalmoscope, Spinal Implants, Polyaxial Screw, Blood Pressure Machine, Heine Sphygmomanometer, Slit Lamp, Ophthalmic Surgical Instruments.
Who are the key members and board of directors at Biomed Healthtech?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nirav Suresh  | Director | 30-Jun-1992 | Current |
| Mayuri Daftary | Director | 31-Mar-1991 | Current |
| Mukesh Daftary | Director | 13-Jun-1989 | Current |
Financial Performance of Biomed Healthtech.
Biomed Healthtech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.3% increase. The company also saw a substantial fall in profitability, with a 15.7% decrease in profit. The company's net worth moved up by a moderate rise of 1.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biomed Healthtech?
In 2022, Biomed Healthtech had a promoter holding of 99.96% and a public holding of 0.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sankalp Placements India LlpActive 6 years 11 months
Mukesh Daftary and Nirav Suresh are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Nkgsb Co-Op. Bank Ltd. Creation Date: 31 Dec 2010 | ₹6.00 M | Satisfied |
The N.K.G.S.B. Co -Op.; Bank Ltd. Creation Date: 02 Dec 2000 | ₹2.00 M | Satisfied |
How Many Employees Work at Biomed Healthtech?
Unlock and access historical data on people associated with Biomed Healthtech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biomed Healthtech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biomed Healthtech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
